SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-17-000338
Filing Date
2017-01-25
Accepted
2017-01-25 11:10:47
Documents
10
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2230622z20-f.htm 20-F 4465248
2 EX-1.1 a2230622zex-1_1.htm EX-1.1 210628
3 EX-12.1 a2230622zex-12_1.htm EX-12.1 13051
4 EX-12.2 a2230622zex-12_2.htm EX-12.2 13118
5 EX-13.1 a2230622zex-13_1.htm EX-13.1 6099
6 EX-13.2 a2230622zex-13_2.htm EX-13.2 6028
7 EX-15.1 a2230622zex-15_1.htm EX-15.1 7100
8 G13392KA01I001.JPG g13392ka01i001.jpg GRAPHIC 2016
9 G13392KA03I001.JPG g13392ka03i001.jpg GRAPHIC 1994
10 G13392KUI001.JPG g13392kui001.jpg GRAPHIC 1800
  Complete submission text file 0001047469-17-000338.txt   4730703
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 17545353
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences